Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Ziemssen T, Groth M, Ettle B, Bopp T.

Verlag

Publisher-Information
Vaccines (Basel). 2022 Dec 16;10(12):2167.

Link

Zur Publikation (externer Server)
https://doi.org/10.3390/vaccines10122167

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
TreatmentsMSZ